首页> 美国政府科技报告 >Modulation of Fibrosis In Scleroderma by 3-Deoxyglucosone.
【24h】

Modulation of Fibrosis In Scleroderma by 3-Deoxyglucosone.

机译:通过3-脱氧葡糖醛酸调节硬皮病中的纤维化。

获取原文

摘要

Scleroderma is a disease where excess collagen is deposited in the skin and internal organs. The tissues become hard and in the end fail to function. To date there is no cure, nor is there an effective therapy that will control the deposition of the collagen. The goals of this application were to investigate the cellular signaling within fibroblasts that were mediated by the glycation end product, 3DG. We find that 3DG decreases the expression of collagens and therefore we proposed to understand the cellular signaling in fibroblasts in response to this compound. 3DG-collagen induced ER stress leading to caspase 3 activation, and decreased cell proliferation. Furthermore, 3DG-collagen induced changes in integrins and growth factor expression. Furthermore, we found that p38 MAPK was a crucial protein that regulated whether the fibroblast responded to a stress signal or a growth signal. The data obtained from this grant has allowed us to identify two candidate chemicals that lower collagen expression by SSc fibroblasts.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号